Publication:
Treatment of pulmonary arteriovenous malformations: clinical experience using different embolization strategies

dc.contributor.authorAkira Adachien_US
dc.contributor.authorKengo Ohtaen_US
dc.contributor.authorYounes Jahangirien_US
dc.contributor.authorYusuke Matsuien_US
dc.contributor.authorMasahiro Horikawaen_US
dc.contributor.authorYindee Geeratikunen_US
dc.contributor.authorOrapin Chansantien_US
dc.contributor.authorShinsaku Yataen_US
dc.contributor.authorShinya Fujiien_US
dc.contributor.authorJonathan Steinbergeren_US
dc.contributor.authorFrederick S. Kelleren_US
dc.contributor.authorKhashayar Farsaden_US
dc.contributor.otherOHSU School of Medicineen_US
dc.contributor.otherOkayama Universityen_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.contributor.otherTottori Universityen_US
dc.contributor.otherRajavithi Hospitalen_US
dc.contributor.otherNagoya City University Graduate School of Medical Sciencesen_US
dc.date.accessioned2020-01-27T03:37:29Z
dc.date.available2020-01-27T03:37:29Z
dc.date.issued2020-01-01en_US
dc.description.abstract© 2020, Japan Radiological Society. Purpose: To evaluate embolization efficacy of pulmonary arteriovenous malformations (PAVM) using Amplatzer vascular plugs (AVP) and coils. Materials and methods: Eighty-eight embolized simple PAVMs in 38 patients were retrospectively analyzed by follow-up CT. Mean age was 50.2 ± 15.6 years and 22 (57.9%) patients were females. Mean follow-up interval was 38.2 ± 28.4 months (median 29.9 months). Embolization devices included AVP I, AVP II, AVP 4, and coils. Technical success was defined as no visualization of an early draining vein at angiography after embolization. Treatment success was defined as complete disappearance or decrease in size of the venous aneurysm ≥ 70% at follow-up CT. Results: Technical success rate was 100% and treatment success rate evaluated by CT for the various embolization strategies was 100% for AVP I (n = 6), 100% for AVP I + coils (n = 5), 83.3% for AVP II (n = 6), 40.0% for AVP II + coils (n = 5), 87.5% for AVP 4 (n = 8), 50.0% for AVP 4 + coils (n = 8), and 78.0% for coils alone (n = 50). No statistically significant difference in embolization efficacy was seen between different devices (P = 0.083). Although not statistically significant, combination use of coils with AVPs demonstrated lower rates of clinical embolization success (P = 0.053). Conclusion: Embolization of PAVMs demonstrated high technical and treatment success rates with available embolic devices. No significant statistical differences were demonstrated between AVPs. However, the need for both coils and AVPs may suggest a more complicated underlying lesion at risk for recurrence.en_US
dc.identifier.citationJapanese Journal of Radiology. (2020)en_US
dc.identifier.doi10.1007/s11604-019-00916-1en_US
dc.identifier.issn1867108Xen_US
dc.identifier.issn18671071en_US
dc.identifier.other2-s2.0-85077558393en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/49667
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85077558393&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleTreatment of pulmonary arteriovenous malformations: clinical experience using different embolization strategiesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85077558393&origin=inwarden_US

Files

Collections